Cargando…
Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?
Autores principales: | Oya, Yuko, Mitsudomi, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261865/ https://www.ncbi.nlm.nih.gov/pubmed/37323182 http://dx.doi.org/10.21037/tlcr-23-97 |
Ejemplares similares
-
Evaluating the intracranial activity of adagrasib
por: Kotecha, Rupesh, et al.
Publicado: (2023) -
Not just another genome
por: Tautz, Diethard
Publicado: (2011) -
Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021) -
Commentary: Aortic root enlargement: Just because we can, does that mean we should?
por: Lau, Christopher, et al.
Publicado: (2020) -
Commentary: We don't need no postop AF… All in all it's just another (β)-block in the wall
por: Mukherjee, Rupak
Publicado: (2020)